A soluble form of the human Fc receptor Fc gamma RIIA: cloning, transcript analysis and detection. 1993

E F Rappaport, and D L Cassel, and D O Walterhouse, and S E McKenzie, and S Surrey, and M A Keller, and A D Schreiber, and E Schwartz
Division of Hematology, Children's Hospital of Philadelphia, PA 19104.

The Fc gamma receptors (Fc gamma R) are glycoproteins that bind the Fc region of immunoglobulin G. Human hematopoietic cells express three biochemically distinct classes of Fc gamma receptors: Fc gamma RI (CD64), Fc gamma RII (CD32) and Fc gamma RIII (CD16). Complementary DNA (cDNA) clones for each of the human Fc gamma receptors have been isolated from myeloid and lymphoid cells. We describe the isolation and characterization of four Fc gamma RII clones from a cDNA library obtained from a megakaryocyte-like cell line, human erythroleukemia (HEL). Three clones encode the Fc gamma RIIA transmembrane (TM) form, while one novel clone lacks the TM region but retains the cytoplasmic domain. By conducting reverse transcription coupled to polymerase chain reaction (PCR), we found transcripts coding for this unique form of receptor in RNA from platelets, HEL cells and a second megakaryocyte-like cell line, CHRF-288-11. These results were confirmed by RNase protection analysis of RNA from HEL cells. The structure of the novel cDNA suggested that it codes for a soluble form of Fc gamma RIIA. A soluble Fc gamma RII protein was detected in the conditioned medium from HEL cells but not from the Fc gamma RII-negative T cell line, Jurkat, by immunoprecipitation with the anti-Fc gamma RII monoclonal antibody (mAb), IV.3. The immunoprecipitated protein was of the expected size for a soluble Fc gamma RII lacking the TM region but retaining the cytoplasmic domain. Soluble Fc gamma RIIA may be important in modulating the interaction between immune complexes and membrane-associated Fc gamma RII.

UI MeSH Term Description Entries
D007163 Immunosorbent Techniques Techniques for removal by adsorption and subsequent elution of a specific antibody or antigen using an immunosorbent containing the homologous antigen or antibody. Immunoadsorbent Techniques,Immunoadsorbent Technics,Immunosorbent Technics,Immunoadsorbent Technic,Immunoadsorbent Technique,Immunosorbent Technic,Immunosorbent Technique,Technic, Immunoadsorbent,Technic, Immunosorbent,Technics, Immunoadsorbent,Technics, Immunosorbent,Technique, Immunoadsorbent,Technique, Immunosorbent,Techniques, Immunoadsorbent,Techniques, Immunosorbent
D008533 Megakaryocytes Very large BONE MARROW CELLS which release mature BLOOD PLATELETS. Megakaryocyte
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011961 Receptors, Fc Molecules found on the surface of some, but not all, B-lymphocytes, T-lymphocytes, and macrophages, which recognize and combine with the Fc (crystallizable) portion of immunoglobulin molecules. Fc Receptors,Fc Receptor,Receptor, Fc
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004915 Leukemia, Erythroblastic, Acute A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood. Di Guglielmo's Disease,Erythremic Myelosis,Erythroblastic Leukemia, Acute,Erythroleukemia,Leukemia, Myeloid, Acute, M6,Myeloid Leukemia, Acute, M6,Di Guglielmo Disease,Acute Erythroblastic Leukemia,Acute Erythroblastic Leukemias,Di Guglielmos Disease,Disease, Di Guglielmo,Disease, Di Guglielmo's,Erythremic Myeloses,Erythroblastic Leukemias, Acute,Erythroleukemias,Leukemia, Acute Erythroblastic,Leukemias, Acute Erythroblastic,Myeloses, Erythremic,Myelosis, Erythremic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

E F Rappaport, and D L Cassel, and D O Walterhouse, and S E McKenzie, and S Surrey, and M A Keller, and A D Schreiber, and E Schwartz
February 1995, Seminars in immunology,
E F Rappaport, and D L Cassel, and D O Walterhouse, and S E McKenzie, and S Surrey, and M A Keller, and A D Schreiber, and E Schwartz
January 1993, Transactions of the Association of American Physicians,
E F Rappaport, and D L Cassel, and D O Walterhouse, and S E McKenzie, and S Surrey, and M A Keller, and A D Schreiber, and E Schwartz
November 1993, Journal of immunological methods,
E F Rappaport, and D L Cassel, and D O Walterhouse, and S E McKenzie, and S Surrey, and M A Keller, and A D Schreiber, and E Schwartz
June 1994, European journal of cell biology,
E F Rappaport, and D L Cassel, and D O Walterhouse, and S E McKenzie, and S Surrey, and M A Keller, and A D Schreiber, and E Schwartz
April 1995, Blood,
E F Rappaport, and D L Cassel, and D O Walterhouse, and S E McKenzie, and S Surrey, and M A Keller, and A D Schreiber, and E Schwartz
May 1999, Immunology letters,
E F Rappaport, and D L Cassel, and D O Walterhouse, and S E McKenzie, and S Surrey, and M A Keller, and A D Schreiber, and E Schwartz
October 2010, The Journal of biological chemistry,
E F Rappaport, and D L Cassel, and D O Walterhouse, and S E McKenzie, and S Surrey, and M A Keller, and A D Schreiber, and E Schwartz
April 1999, Journal of immunology (Baltimore, Md. : 1950),
E F Rappaport, and D L Cassel, and D O Walterhouse, and S E McKenzie, and S Surrey, and M A Keller, and A D Schreiber, and E Schwartz
July 2003, Journal of neuroimmunology,
E F Rappaport, and D L Cassel, and D O Walterhouse, and S E McKenzie, and S Surrey, and M A Keller, and A D Schreiber, and E Schwartz
April 2002, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!